Ironwood Pharmaceuticals (IRWD) Notes Payables (2014 - 2019)

Ironwood Pharmaceuticals has disclosed Notes Payables across 5 years of filings, most recently posting $48.8 million for Q2 2019.

• Notes Payables for Q2 2019 came in at $48.8 million, up 96.28% year-over-year; the trailing twelve-month figure through Jun 2019 was $48.8 million (up 96.28% YoY), and the FY2018 annual result was $47.6 million, changed N/A from the prior year.
• Notes Payables came in at $48.8 million for Q2 2019 at Ironwood Pharmaceuticals, up from $46.0 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $48.8 million in Q2 2019 to a low of $8.4 million in Q3 2016.
• The 4-year median for Notes Payables is $25.0 million (2015), against an average of $28.2 million.
• Across the five-year window, Notes Payables slumped 58.23% in 2016 and surged 284.35% in 2019, its largest moves.
• Ironwood Pharmaceuticals' Notes Payables stood at $25.0 million in 2015, then sank by 66.33% to $8.4 million in 2016, then soared by 465.78% to $47.6 million in 2018, then grew by 2.61% to $48.8 million in 2019.
• The last three Notes Payables figures came in at $48.8 million (Q2 2019), $46.0 million (Q1 2019), and $47.6 million (Q4 2018), per Business Quant data.